|
RNF150 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.4718009557273E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.93809462606987E-14 |
| Normal-vs-Stage2 |
1.50499612772137E-11 |
| Normal-vs-Stage3 |
3.14193115968919E-14 |
| Normal-vs-Stage4 |
1.66533453693773E-15 |
| Stage1-vs-Stage2 |
9.501200E-03 |
| Stage1-vs-Stage3 |
3.916400E-01 |
| Stage1-vs-Stage4 |
1.81176999999311E-05 |
| Stage2-vs-Stage3 |
8.795400E-03 |
| Stage2-vs-Stage4 |
1.99646999999858E-05 |
| Stage3-vs-Stage4 |
2.590300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67033054054855E-12 |
| Normal-vs-AfricanAmerican |
8.1601392309949E-14 |
| Normal-vs-Asian |
1.63280500231622E-12 |
| Caucasian-vs-AfricanAmerican |
9.290800E-01 |
| Caucasian-vs-Asian |
1.216840E-01 |
| AfricanAmerican-vs-Asian |
2.594800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.58282325818982E-14 |
| Normal-vs-Female |
1.68964842117703E-12 |
| Male-vs-Female |
8.376000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24265050974282E-14 |
| Normal-vs-Age(41-60Yrs) |
1.01585406753202E-13 |
| Normal-vs-Age(61-80Yrs) |
1.77802217393719E-12 |
| Normal-vs-Age(81-100Yrs) |
2.164700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.592840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.399610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.175400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.611600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.168400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.545800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.72970004985729E-09 |
| Classical-VS-Follicular |
1.52119999999867E-05 |
| Classical-VS-Other |
2.412400E-01 |
| Classical-VS-Normal |
4.55191440096314E-14 |
| Tall-VS-Follicular |
7.48212602985632E-12 |
| Tall-VS-Other |
1.689780E-01 |
| Tall-VS-Normal |
1.62525548574877E-12 |
| Follicular-VS-Other |
1.827730E-04 |
| Follicular-VS-Normal |
8.63500382308757E-11 |
| Other-VS-Normal |
1.65356617287671E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96498373128406E-12 |
| Normal-vs-N1 |
1.62680979798324E-12 |
| N0-vs-N1 |
6.644300E-04 |
|
|
